The first Intellia Therapeutics trade was made in Q2 2021.
Since then Andreas Halvorsen bought shares four more times and sold shares on four occasions. The investor completely sold their stake between Q1 2023 and Q2 2023.
Avg closing price
Price range
Sold -1.57 Million shares
Q2 2023
Avg closing price
$40.55
Price range
$34.58
-
$46.03
Sold 22.4% shares (-452 Thousand shares)
Q1 2023
Avg closing price
$39.22
Price range
$33.30
-
$44.82
Increased shares by 7.0% (+132 Thousand shares)
Q4 2022
Avg closing price
$47.55
Price range
$33.21
-
$62.69
Sold 15.2% shares (-339 Thousand shares)
Q3 2022
Avg closing price
$62.04
Price range
$53.92
-
$71.70
Sold 9.7% shares (-240 Thousand shares)
Q2 2022
Avg closing price
$50.78
Price range
$38.49
-
$76.21
Increased shares by 56.3% (+889 Thousand shares)
Q1 2022
Avg closing price
$84.72
Price range
$58.27
-
$118.99
Increased shares by 23.4% (+300 Thousand shares)
Q4 2021
Avg closing price
$125.27
Price range
$100.76
-
$138.36
Increased shares by 31.2% (+304 Thousand shares)
Q3 2021